Prothena Corp. PLC | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.2 |
Market Cap |
$403.83 M |
Shares Outstanding |
39.87 M |
Public Float |
39.89 M |
Address |
77 Sir John Rogersons Quay Dun Laoghaire Dublin 2 Ireland |
Employees | - |
Website | http://www.prothena.com |
Updated | 07/08/2019 |
Prothena Corp. Plc is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. The company was founded on December 20, 2012 and is headquartered in Dun Laoghaire, Ireland. |